Search Within

James Joseph Harding

  1. "Early Drug Development Service"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
Groups
  1. Department of Medicine (24)
  2. Early Drug Development Service (24)
  3. Gastrointestinal Oncology Service (24)
  4. Solid Tumor Oncology Division (24)
  5. Genitourinary Oncology Service (17)
  6. Department of Pathology and Laboratory Medicine (16)

More Groups

People
  1. David Hyman (20)
  2. Alexander Drilon (13)
  3. Michael Berger (12)
  4. Alison Schram (11)
  5. David Solit (11)
  6. Nikolaus Schultz (10)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (2)
  4. Investigational New Drugs (2)
  5. JCO Precision Oncology (2)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (2)
  4. Oxford University Press (2)
  5. Springer (2)
  6. American Medical Association (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save